KR920008817B1 - 조절된 방출성(서방성) 약학적 제제의 제조방법. - Google Patents

조절된 방출성(서방성) 약학적 제제의 제조방법. Download PDF

Info

Publication number
KR920008817B1
KR920008817B1 KR1019860008136A KR860008136A KR920008817B1 KR 920008817 B1 KR920008817 B1 KR 920008817B1 KR 1019860008136 A KR1019860008136 A KR 1019860008136A KR 860008136 A KR860008136 A KR 860008136A KR 920008817 B1 KR920008817 B1 KR 920008817B1
Authority
KR
South Korea
Prior art keywords
release
fatty acid
capsule
pindorol
hydroxypropylmethylcellulose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
KR1019860008136A
Other languages
English (en)
Korean (ko)
Other versions
KR870003777A (ko
Inventor
쥬거 오트마
Original Assignee
산도즈 파마슈티칼스 코오포레이숀
제랄드 디. 샤르킨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858524135A external-priority patent/GB8524135D0/en
Priority claimed from GB858524653A external-priority patent/GB8524653D0/en
Priority claimed from GB858531419A external-priority patent/GB8531419D0/en
Priority claimed from GB868603097A external-priority patent/GB8603097D0/en
Priority claimed from GB868605037A external-priority patent/GB8605037D0/en
Application filed by 산도즈 파마슈티칼스 코오포레이숀, 제랄드 디. 샤르킨 filed Critical 산도즈 파마슈티칼스 코오포레이숀
Publication of KR870003777A publication Critical patent/KR870003777A/ko
Application granted granted Critical
Publication of KR920008817B1 publication Critical patent/KR920008817B1/ko
Expired legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
KR1019860008136A 1985-10-01 1986-09-29 조절된 방출성(서방성) 약학적 제제의 제조방법. Expired KR920008817B1 (ko)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
GB8524135 1985-10-01
GB858524135A GB8524135D0 (en) 1985-10-01 1985-10-01 Darodipine compositions
GB8524653 1985-10-07
GB858524653A GB8524653D0 (en) 1985-10-07 1985-10-07 Pharmaceutical formulations
GB8531419 1985-12-20
GB858531419A GB8531419D0 (en) 1985-12-20 1985-12-20 Pindolol compositions
GB868603097A GB8603097D0 (en) 1986-02-07 1986-02-07 Pharmaceutical formulations
GB8603097 1986-02-07
GB8605037 1986-02-28
GB868605037A GB8605037D0 (en) 1986-02-28 1986-02-28 Oral pharmaceutical compositions

Publications (2)

Publication Number Publication Date
KR870003777A KR870003777A (ko) 1987-05-04
KR920008817B1 true KR920008817B1 (ko) 1992-10-09

Family

ID=27516617

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019860008136A Expired KR920008817B1 (ko) 1985-10-01 1986-09-29 조절된 방출성(서방성) 약학적 제제의 제조방법.

Country Status (20)

Country Link
KR (1) KR920008817B1 (enExample)
AT (1) AT402257B (enExample)
BE (1) BE905516A (enExample)
CA (1) CA1298784C (enExample)
CH (1) CH669524A5 (enExample)
DE (1) DE3632201C2 (enExample)
DK (1) DK170016B1 (enExample)
ES (1) ES2002508A6 (enExample)
FR (1) FR2589732B1 (enExample)
GR (1) GR862457B (enExample)
HK (1) HK392A (enExample)
HU (1) HU197201B (enExample)
IE (1) IE59589B1 (enExample)
IL (1) IL80182A (enExample)
LU (1) LU86615A1 (enExample)
NL (1) NL194822C (enExample)
NZ (1) NZ217732A (enExample)
PT (1) PT83456B (enExample)
SE (1) SE503222C2 (enExample)
SG (1) SG103391G (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440457B1 (en) 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
WO2003065970A2 (en) * 2001-02-20 2003-08-14 Royal College Of Surgeons Ie Treatment of fibromyalgia and related fatigue syndromes using pindolol
TW200616681A (en) * 2004-10-05 2006-06-01 Recordati Ireland Ltd Lercanidipine capsules

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
CH639659A5 (de) * 1978-12-18 1983-11-30 Sandoz Ag Neue 1,4-dihydropyridinderivate, deren herstellung und verwendung.
DD145004A3 (de) * 1978-09-25 1980-11-19 Reinhard Huettenrauch Verfahren zur herstellung fester a zneiformen
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
JPS6056122B2 (ja) * 1980-05-21 1985-12-09 塩野義製薬株式会社 徐放性製剤
GB2084017B (en) * 1980-09-18 1984-08-22 Sandoz Ltd Pharmaceutical compositions effective against coronary heat disease and hypertension
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
CA1208558A (en) * 1982-10-07 1986-07-29 Kazuo Kigasawa Soft buccal
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
KR850700212A (ko) * 1984-03-21 1985-12-26 죠지 드모트 서방성 약제학적 캼셀제
JPS6124516A (ja) * 1984-07-12 1986-02-03 Fujisawa Pharmaceut Co Ltd 持続性錠剤

Also Published As

Publication number Publication date
HU197201B (en) 1989-03-28
ES2002508A6 (es) 1988-08-16
SE8604112L (sv) 1987-04-02
PT83456B (pt) 1989-05-12
IL80182A (en) 1991-01-31
KR870003777A (ko) 1987-05-04
IE59589B1 (en) 1994-03-09
HK392A (en) 1992-01-10
AT402257B (de) 1997-03-25
IE862565L (en) 1987-04-01
DE3632201A1 (de) 1987-04-02
CH669524A5 (enExample) 1989-03-31
DK464686D0 (da) 1986-09-29
ATA260486A (de) 1996-08-15
GR862457B (en) 1987-01-29
SE8604112D0 (sv) 1986-09-29
HUT44701A (en) 1988-04-28
DK464686A (da) 1987-04-02
LU86615A1 (fr) 1987-04-02
DE3632201C2 (de) 1997-05-07
PT83456A (en) 1986-10-01
DK170016B1 (da) 1995-05-01
CA1298784C (en) 1992-04-14
IL80182A0 (en) 1986-12-31
SE503222C2 (sv) 1996-04-22
BE905516A (fr) 1987-03-30
FR2589732B1 (fr) 1989-07-13
SG103391G (en) 1992-01-17
NL194822B (nl) 2002-12-02
NZ217732A (en) 1990-07-26
NL194822C (nl) 2003-04-03
FR2589732A1 (fr) 1987-05-15
NL8602370A (nl) 1987-05-04

Similar Documents

Publication Publication Date Title
JP3889481B2 (ja) 医薬組成物
US5071642A (en) Dihydropyridine containing compositions
US5399360A (en) Pharmaceutical compositions
GB2154874A (en) Bromocriptine compositions
GB2181053A (en) Controlled release formulation
KR920008817B1 (ko) 조절된 방출성(서방성) 약학적 제제의 제조방법.
KR920010388B1 (ko) 9,10-디하이드로 에르고트 알카로이드를 함유하는 서방성 약학제제의 제조방법
BE1010972A6 (fr) Composition pharmaceutique antituberculeuse et procede destine a produire ladite composition.
US5069911A (en) Pharmaceutical 9,10-dihydrogenated ergot alkaloid containing compositions
AU618599B2 (en) Controlled release bromocriptine formulations
AU598751B2 (en) Pharmaceutical formulations with controlled release of the active substance
JPS62149618A (ja) 活性物質放出制御医薬製剤
EP0425902A1 (en) Use of isosorbide 2-mononitrate in the preparation of pharmaceutical compositions for treating angina pectoris
HU204997B (en) Process for producing carrier system suitable for ensuring controlled biological access to dihydropyridines, as well as new oral dosage form ensuring improved biological access
JPH0466846B2 (enExample)
KR950007229B1 (ko) 케토티펜을 함유한 약학적 조성물
Epstein Rate Control Versus Rhythm Control for Atrial Fibrillation–Implications of Recent Clinical Trials for Clinical Practice
JPH0155245B2 (enExample)
HK1001822B (en) Medicinal form for oral application for the once-a-day treatment of hypertension by diltiazem hydrochloride

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19860929

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19870926

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19860929

Comment text: Patent Application

E601 Decision to refuse application
E902 Notification of reason for refusal
PE0601 Decision on rejection of patent

Patent event date: 19890907

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19890907

Patent event code: PE09021S01D

J2X1 Appeal (before the patent court)

Free format text: APPEAL AGAINST DECISION TO DECLINE REFUSAL

PJ2001 Appeal

Appeal kind category: Appeal against decision to decline refusal

Decision date: 19911130

Appeal identifier: 1990201001103

Request date: 19900824

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19911230

Patent event code: PE09021S01D

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

Comment text: Decision on Publication of Application

Patent event code: PG16051S01I

Patent event date: 19920909

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 19930109

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 19930308

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 19930308

End annual number: 3

Start annual number: 1

PR1001 Payment of annual fee

Payment date: 19950918

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 19960913

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 19970807

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 19980827

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 19990915

Start annual number: 8

End annual number: 8

PR1001 Payment of annual fee

Payment date: 20000825

Start annual number: 9

End annual number: 9

PR1001 Payment of annual fee

Payment date: 20010904

Start annual number: 10

End annual number: 10

PR1001 Payment of annual fee

Payment date: 20020826

Start annual number: 11

End annual number: 11

PR1001 Payment of annual fee

Payment date: 20030826

Start annual number: 12

End annual number: 12

PR1001 Payment of annual fee

Payment date: 20040819

Start annual number: 13

End annual number: 13

FPAY Annual fee payment

Payment date: 20050817

Year of fee payment: 14

PR1001 Payment of annual fee

Payment date: 20050817

Start annual number: 14

End annual number: 14

EXPY Expiration of term
PC1801 Expiration of term